The intestinal microbiota fuelling metabolic inflammation

Author: Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E.

Description: Low-grade inflammation is the hallmark of metabolic disorders such as obesity, type 2 diabetes and nonalcoholic fatty liver disease. Emerging evidence indicates that these disorders are characterized by alterations in the intestinal microbiota composition and its metabolites, which translocate from the gut across a disrupted intestinal barrier to affect various metabolic organs, such as the liver and adipose tissue, thereby contributing to metabolic inflammation. Here, we discuss some of the recently identified mechanisms that showcase the role of the intestinal microbiota and barrier dysfunction in metabolic inflammation. We propose a concept by which the gut microbiota fuels metabolic inflammation and dysregulation.

Subject headings: Animals; Chronic Disease; Dysbiosis; Gastrointestinal Microbiome; Humans; Inflammation; Intestinal Mucosa; Metabolic Diseases; Gut

Publication year: 2020

Journal or book title: Nature Reviews. Immunology

Volume: 20

Issue: 1

Pages: 40–54

Find the full text: https://www.weizmann.ac.il/immunology/elinav/sites/immunology.elinav/files/2019_elinav_nature_reviews_immunology.pdf

Find more like this one (cited by): https://scholar.google.com/scholar?cites=15006946852812890254&as_sdt=1000005&sciodt=0,16&hl=en

Type: Journal article

Serial number: 3133

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.